1a medical device for covid

  1. 722 Posts.
    lightbulb Created with Sketch. 102
    Just watched the news and current affair program. Hospitals in some areas full at capacity. New covid wards being created. More people needing hospital assistance by the day. ICU admissions up 50% in nsw in one week. Doctors and nurses from different departments needing to learn how to treat covid patients very quickly.
    Uscom 1a was recommended as the covid device of choice by the Chinese medical board and is now being added to their new 50 infectious disease centres. Also note that apparently uscom 1a can be trained for new medical users in less than 2 days which is significantly less time than other similar devices.
    Then checked the just released chairman’s letter and note that our life saving covid assisting medical device has sales in its own country Australia of minimal Australian sales of 2% of It’s total worldwide sales. Our govt is rightly spending billions trying to save Australians with vaccines and medical assistance yet we can’t get our own Australian made and produced world accredited devices on mass in our own hospitals that are recommended covid devices of choice overseas.
    Feel like writing to our pm, national and state health ministers, local members , news and talk back radio programs asking why. Doesn’t make sense and would love to know the reason why it has had such minimal sales and interest in Australia..
    Rant over.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $4.759M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 500000 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 46000 1
View Market Depth
Last trade - 16.21pm 26/06/2025 (20 minute delay) ?
UCM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.